Stephen Baxter
Stock Analyst at Wells Fargo
(3.11)
# 2,434
Out of 4,352 analysts
660
Total ratings
46.8%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Maintained: Buy | $391 | $393.19 | -0.56% | 47 | May 29, 2026 | |
| COR Cencora | Reiterated: Buy | $331 | $269.36 | +22.88% | 22 | May 28, 2026 | |
| CVS CVS Health | Maintained: Buy | $103 | $90.98 | +13.21% | 47 | May 20, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $397 | $380.31 | +4.39% | 50 | May 20, 2026 | |
| LMRI Lumexa Imaging Holdings | Maintained: Buy | $22 → $19 | $7.78 | +144.22% | 3 | May 13, 2026 | |
| MCK McKesson | Maintained: Hold | $925 → $812 | $742.44 | +9.37% | 25 | May 12, 2026 | |
| MOH Molina Healthcare | Rated: Hold | $159 | $173.60 | -8.41% | 50 | May 10, 2026 | |
| PNTG The Pennant Group | Maintained: Buy | $38 → $41 | $34.25 | +19.71% | 9 | May 9, 2026 | |
| OSCR Oscar Health | Reiterated: Sell | $11 | $22.23 | -50.52% | 30 | May 7, 2026 | |
| AGL agilon health | Maintained: Buy | $38 → $72 | $92.28 | -21.98% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 | $36.56 | +28.56% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $61 | $61.68 | -1.10% | 20 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $44 → $56 | $59.60 | -6.04% | 49 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 → $305 | $277.40 | +9.95% | 38 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $227 | $305.42 | -25.68% | 58 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $2 | $2.72 | -26.47% | 28 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $481 → $436 | $378.54 | +15.18% | 30 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $256 | $196.80 | +30.08% | 21 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $265 | $175.32 | +51.15% | 31 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $28 | $24.87 | +12.59% | 10 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $235 → $212 | $146.11 | +45.10% | 32 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $7.61 | +5.12% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $40 | $9.83 | n/a | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $235 | $260.06 | n/a | 6 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $88 → $91 | $447.11 | n/a | 2 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $116 | $194.90 | n/a | 1 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $203 | $180.71 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $182.21 | n/a | 1 | Nov 14, 2019 |
Elevance Health
May 29, 2026
Maintained: Buy
Price Target: $391
Current: $393.19
Upside: -0.56%
Cencora
May 28, 2026
Reiterated: Buy
Price Target: $331
Current: $269.36
Upside: +22.88%
CVS Health
May 20, 2026
Maintained: Buy
Price Target: $103
Current: $90.98
Upside: +13.21%
UnitedHealth Group
May 20, 2026
Maintained: Buy
Price Target: $397
Current: $380.31
Upside: +4.39%
Lumexa Imaging Holdings
May 13, 2026
Maintained: Buy
Price Target: $22 → $19
Current: $7.78
Upside: +144.22%
McKesson
May 12, 2026
Maintained: Hold
Price Target: $925 → $812
Current: $742.44
Upside: +9.37%
Molina Healthcare
May 10, 2026
Rated: Hold
Price Target: $159
Current: $173.60
Upside: -8.41%
The Pennant Group
May 9, 2026
Maintained: Buy
Price Target: $38 → $41
Current: $34.25
Upside: +19.71%
Oscar Health
May 7, 2026
Reiterated: Sell
Price Target: $11
Current: $22.23
Upside: -50.52%
agilon health
May 7, 2026
Maintained: Buy
Price Target: $38 → $72
Current: $92.28
Upside: -21.98%
May 7, 2026
Reiterated: Hold
Price Target: $47
Current: $36.56
Upside: +28.56%
May 4, 2026
Rated: Buy
Price Target: $50 → $61
Current: $61.68
Upside: -1.10%
May 1, 2026
Maintained: Hold
Price Target: $44 → $56
Current: $59.60
Upside: -6.04%
May 1, 2026
Maintained: Hold
Price Target: $300 → $305
Current: $277.40
Upside: +9.95%
Apr 30, 2026
Maintained: Hold
Price Target: $227
Current: $305.42
Upside: -25.68%
Apr 27, 2026
Rated: Sell
Price Target: $2
Current: $2.72
Upside: -26.47%
Apr 27, 2026
Rated: Hold
Price Target: $481 → $436
Current: $378.54
Upside: +15.18%
Apr 13, 2026
Rated: Buy
Price Target: $256
Current: $196.80
Upside: +30.08%
Apr 13, 2026
Rated: Buy
Price Target: $265
Current: $175.32
Upside: +51.15%
Mar 5, 2026
Maintained: Buy
Price Target: $25 → $28
Current: $24.87
Upside: +12.59%
Mar 2, 2026
Maintained: Hold
Price Target: $235 → $212
Current: $146.11
Upside: +45.10%
Oct 29, 2025
Maintained: Hold
Price Target: $8
Current: $7.61
Upside: +5.12%
May 1, 2024
Maintained: Hold
Price Target: $4 → $40
Current: $9.83
Upside: n/a
Jan 11, 2021
Downgraded: Hold
Price Target: $235
Current: $260.06
Upside: n/a
May 13, 2020
Downgraded: Hold
Price Target: $88 → $91
Current: $447.11
Upside: n/a
Apr 27, 2020
Upgraded: Hold
Price Target: $116
Current: $194.90
Upside: n/a
Feb 18, 2020
Upgraded: Buy
Price Target: $203
Current: $180.71
Upside: n/a
Nov 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $182.21
Upside: n/a